Approvals in 2019: international review and a new agnostic molecular entity
Sign Up to like & getrecommendations! Published in 2020 at "Nature Reviews Clinical Oncology"
DOI: 10.1038/s41571-020-0336-8
Abstract: In 2019, the FDA Oncology Center of Excellence (OCE) approved 11 new drugs and biologic agents, 30 supplemental drug and biologic applications, and four biosimilar applications in oncology. These included two landmark approvals involving collaboration… read more here.
Keywords: review new; 2019 international; new agnostic; approvals 2019 ... See more keywords
Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention
Sign Up to like & getrecommendations! Published in 2020 at "ecancermedicalscience"
DOI: 10.3332/ecancer.2020.998
Abstract: At the 2019 International Aspirin Foundation Scientific Conference ‘Benefits and Risks of Antithrombotic Therapy for Cardiovascular Disease Prevention’, held in Rome, Italy, international experts sought to discuss and debate the optimal antithrombotic strategy for the… read more here.
Keywords: 2019 international; disease prevention; cardiovascular disease; prevention ... See more keywords
A Special Report on 2019 International Planning Competition and a Comprehensive Analysis of Its Results
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.571644
Abstract: Purpose The aim of this work is to introduce the 2019 International Planning Competition and to analyze its results. Methods and materials A locally advanced non-small cell lung cancer (LA-NSCLC) case using the simultaneous integrated… read more here.
Keywords: international planning; 2019 international; planning competition; plan ... See more keywords